DCM
CLBT icon

Driehaus Capital Management’s Cellebrite CLBT Stock Holding History

Driehaus Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,036,022
Closed -$20.1M – 434
2025
Q1 		$20.1M Buy
1,036,022
+493,194
+91% +$10.4M 0.19% 158
2024
Q4 		$12M Buy
+542,828
New +$10.4M 0.1% 229

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Driehaus Capital Management's CLBT Position: Q2 2025 in Review

Driehaus Capital Management sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 1,036,022 shares — an estimated $20.1M sold.

Driehaus Capital Management first reported a position in CLBT in Q4 2024 and held it in 2 quarters. The position peaked at $20.1M in Q1 2025. 208 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Driehaus Capital Management reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Driehaus Capital Management sold 1,036,022 Cellebrite shares in Q2 2025, an estimated $20.1M.
  • Driehaus Capital Management first reported a position in Cellebrite in Q4 2024 and held it in 2 quarters.
  • Driehaus Capital Management's Cellebrite position peaked at $20.1M in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Driehaus Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.